Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer

Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer

Show other versions (1)

<h4>Introduction</h4> There are no reliable blood biomarkers for monitoring endometrial cancer patients in the current clinical practice. Circulating tumor DNA (ctDNA) is emerging as a promising non-invasive method to measure tumor burden, define prognosis and monitor disease status in m...

Full description

Bibliographic Details
Main Authors: Tommaso Grassi, Faye R. Harris, James B. Smadbeck, Stephen J. Murphy, Matthew S. Block, Francesco Multinu, Janet L. Schaefer Klein, Piyan Zhang, Giannoula Karagouga, Minetta C. Liu, Alyssa Larish, Maureen A. Lemens, Marla Kay S. Sommerfield, Serena Cappuccio, John C. Cheville, George Vasmatzis, Andrea Mariani
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192008/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192008/?tool=EBI

Similar Items